HuLuc63
| HuLuc63 | |
|---|---|
| Term | HuLuc63 |
| Short definition | HuLuc63 - A drug used along with dexamethasone and either lenalidomide or pomalidomide to treat adults with multiple myeloma. It is used in patients whose cancer has already been treated with other cancer treatments. HuLuc63 binds to a protein called CS1, which is found on myeloma cells and some types of immune cells. HuLuc63 can block CS1 and help the immune system kill cancer cells. It's a type of monoclonal antibody. Also called elotuzumab and empliciti |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
HuLuc63 - A drug used along with dexamethasone and either lenalidomide or pomalidomide to treat adults with multiple myeloma. It is used in patients whose cancer has already been treated with other cancer treatments. HuLuc63 binds to a protein called CS1, which is found on myeloma cells and some types of immune cells. HuLuc63 can block CS1 and help the immune system kill cancer cells. It's a type of monoclonal antibody. Also called elotuzumab and empliciti
External links
- Medical encyclopedia article on HuLuc63
- Wikipedia's article - HuLuc63
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski